Dr. Todd A. Pezzi, MD

Dr. Pezzi practices at Advocate Radiation Oncology in Port Charlotte, Florida.

Dr. Pezzi's NPI, 1336674431, was assigned on April 26, 2017. Dr. Pezzi graduated from Baylor College Of Medicine in 2016. Dr. Pezzi holds Florida license ME153410.

Dr. Pezzi's primary practice is Advocate Radiation Oncology, at 3080 Harbor Blvd, Port Charlotte, FL 33952 in Charlotte County. The practice phone is (941) 883-2199.

Dr. Pezzi's primary practice is Advocate Radiation Oncology in Port Charlotte, Florida. Dr. Pezzi is also affiliated with Lee Memorial Hospital. The medical group on file is Advocate Radiation Oncology. Dmand AI also links Dr. Pezzi to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pezzi practices, 8 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Pezzi's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Pezzi is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Pezzi's licenses on file in 3 states: Florida, Texas and Pennsylvania.

Dmand AI lists anal cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation and lung cancer radiation among the conditions Dr. Pezzi treats.

CMS data shows 9,949 Medicare services from Dr. Pezzi across 28 procedure codes in 2024, for 495 Medicare patients. Medicare paid $1,899,239 for them. Every service was in an office.

CMS counts 495 Medicare patients who saw Dr. Pezzi in 2024. The largest group is 75 to 84, with 225 patients. 75% of them have cancer, and 75% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pezzi's median patient age at 75, with 15% women.

In 2024, Dr. Pezzi wrote 44 Medicare Part D claims for 27 patients. 100% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $154 in total drug cost. In 2023, CMS named 72 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Pezzi for performance year 2024, reported as part of a group. Dr. Pezzi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pezzi as offering telehealth.

Dmand AI links 33 papers to Dr. Pezzi, published from 2013 to 2024. 2020 was the busiest year, with 6. The most frequent topics are Lung Neoplasms, Small Cell Lung Carcinoma and Carcinoma, Non-Small-Cell Lung. Dr. Pezzi has published most often in JAMA Netw Open. Dr. Pezzi's most frequent co-authors are Christopher Mario Pezzi, MD, Olsi Gjyshi, MD, PhD and Stephen G. Chun, MD.

Dmand AI links Dr. Pezzi to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Small Cell Lung Carcinoma and Brain Neoplasms.

CMS Open Payments shows 45 general payments to Dr. Pezzi from 17 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 86% of the total. AstraZeneca Pharmaceuticals LP paid the most, $964.

Dmand AI lists 6 awards for Dr. Pezzi, most recently A Lavoy Moore Fellowship in Lung Cancer Research in 2021.

Dr. Pezzi graduated from Baylor College Of Medicine in 2016.

Dr. Pezzi is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.